Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-091296
Filing Date
2021-03-23
Accepted
2021-03-23 16:57:58
Documents
5
Effectiveness Date
2021-03-23

Document Format Files

Seq Description Document Type Size
1 S-8 d156508ds8.htm S-8 49047
2 EX-5.1 d156508dex51.htm EX-5.1 11632
3 EX-23.2 d156508dex232.htm EX-23.2 1558
4 GRAPHIC g156508dsp10lw.jpg GRAPHIC 2546
5 GRAPHIC g156508dsp9lw.jpg GRAPHIC 4255
  Complete submission text file 0001193125-21-091296.txt   72929
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254628 | Film No.: 21765439
SIC: 2836 Biological Products, (No Diagnostic Substances)